4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001209191-10-035483
CIK 0001006281other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:12 PM ET
Size
5.2 KB
Accession
0001209191-10-035483
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2010-06-21$7.00/sh−52,973$370,811→ 816,781 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:12 PM ET
- Size
- 5.2 KB